ZA92428B - N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept(b)indole - Google Patents
N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept(b)indoleInfo
- Publication number
- ZA92428B ZA92428B ZA92428A ZA92428A ZA92428B ZA 92428 B ZA92428 B ZA 92428B ZA 92428 A ZA92428 A ZA 92428A ZA 92428 A ZA92428 A ZA 92428A ZA 92428 B ZA92428 B ZA 92428B
- Authority
- ZA
- South Africa
- Prior art keywords
- branched
- alkyl
- hydrogen
- straight
- independently
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919101375A GB9101375D0 (en) | 1991-01-22 | 1991-01-22 | N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA92428B true ZA92428B (en) | 1992-10-28 |
Family
ID=10688812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA92428A ZA92428B (en) | 1991-01-22 | 1992-01-21 | N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept(b)indole |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5238953A (xx) |
| EP (1) | EP0496237B1 (xx) |
| JP (1) | JPH04321683A (xx) |
| KR (1) | KR920014806A (xx) |
| AT (1) | ATE134191T1 (xx) |
| AU (1) | AU641837B2 (xx) |
| CA (1) | CA2059741A1 (xx) |
| DE (1) | DE69208271D1 (xx) |
| FI (1) | FI920247A (xx) |
| GB (1) | GB9101375D0 (xx) |
| HU (1) | HUT60492A (xx) |
| IE (1) | IE920173A1 (xx) |
| IL (1) | IL100646A (xx) |
| MX (1) | MX9200178A (xx) |
| MY (1) | MY106807A (xx) |
| NZ (1) | NZ241317A (xx) |
| TW (1) | TW203610B (xx) |
| ZA (1) | ZA92428B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU685122B2 (en) * | 1993-06-14 | 1998-01-15 | Pfizer Inc. | Imidazole lipoxygenase inhibitors |
| DE4435477A1 (de) | 1994-10-04 | 1996-04-11 | Bayer Ag | Cycloalkano-indol- und -azaindol-derivate |
| US6713645B1 (en) * | 1996-10-30 | 2004-03-30 | Eli Lilly And Company | Substituted tricyclics |
| US6177440B1 (en) | 1996-10-30 | 2001-01-23 | Eli Lilly And Company | Substituted tricyclics |
| US6410583B1 (en) | 2000-07-25 | 2002-06-25 | Merck Frosst Canada & Co. | Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| AR038136A1 (es) | 2002-01-24 | 2004-12-29 | Merck Frosst Canada Inc | Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE486478A (xx) * | 1947-12-24 | |||
| GB1418703A (en) * | 1973-06-02 | 1975-12-24 | Pfizer Ltd | 3-alkyl-9-substituted-1,2,3,4-tetrahydrocarbazoles |
| CA1046519A (en) * | 1975-08-28 | 1979-01-16 | American Home Products Corporation | Trycyclic acetic acid derivatives |
| ZA825413B (en) * | 1981-08-26 | 1983-06-29 | Pfizer | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them |
| US4436746A (en) * | 1982-09-30 | 1984-03-13 | Ciba-Geigy Corporation | Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles |
| ES2038653T3 (es) * | 1986-01-23 | 1993-08-01 | Merck Frosst Canada Inc. | Acidos 1-alcanoicos tetrahidrocarbazol. |
| US4808608A (en) * | 1986-01-23 | 1989-02-28 | Merck & Co., Inc. | Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use |
| US4940719A (en) * | 1986-03-27 | 1990-07-10 | Merck Frosst Canada, Inc. | Tetrahydrocarbazole esters, pharmaceutical compositions and use |
| CA1326030C (en) * | 1987-07-21 | 1994-01-11 | John W. Gillard | Cyclohept[b]indolealkanoic acids |
| DK185489A (da) * | 1988-04-22 | 1989-10-23 | Duphar Int Res | Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse |
| IL91542A0 (en) * | 1988-10-06 | 1990-04-29 | Erba Carlo Spa | N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them |
| US5221678A (en) * | 1990-07-26 | 1993-06-22 | Merck Frosst Canada, Inc. | (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
| US5187180A (en) * | 1990-07-26 | 1993-02-16 | Merck Frosst Canada, Inc. | (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
-
1991
- 1991-01-22 GB GB919101375A patent/GB9101375D0/en active Pending
-
1992
- 1992-01-13 DE DE69208271T patent/DE69208271D1/de not_active Expired - Lifetime
- 1992-01-13 EP EP92100414A patent/EP0496237B1/en not_active Expired - Lifetime
- 1992-01-13 AT AT92100414T patent/ATE134191T1/de active
- 1992-01-14 IL IL10064692A patent/IL100646A/en not_active IP Right Cessation
- 1992-01-14 AU AU10207/92A patent/AU641837B2/en not_active Ceased
- 1992-01-16 MX MX9200178A patent/MX9200178A/es not_active Application Discontinuation
- 1992-01-16 TW TW081100277A patent/TW203610B/zh active
- 1992-01-16 NZ NZ241317A patent/NZ241317A/xx unknown
- 1992-01-20 KR KR1019920000731A patent/KR920014806A/ko not_active Application Discontinuation
- 1992-01-20 FI FI920247A patent/FI920247A/fi not_active Application Discontinuation
- 1992-01-21 ZA ZA92428A patent/ZA92428B/xx unknown
- 1992-01-21 HU HU9200190A patent/HUT60492A/hu unknown
- 1992-01-21 CA CA002059741A patent/CA2059741A1/en not_active Abandoned
- 1992-01-21 US US07/824,240 patent/US5238953A/en not_active Expired - Fee Related
- 1992-01-21 IE IE017392A patent/IE920173A1/en unknown
- 1992-01-21 MY MYPI92000086A patent/MY106807A/en unknown
- 1992-01-22 JP JP4009486A patent/JPH04321683A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATE134191T1 (de) | 1996-02-15 |
| CA2059741A1 (en) | 1992-07-23 |
| US5238953A (en) | 1993-08-24 |
| HU9200190D0 (en) | 1992-04-28 |
| IL100646A0 (en) | 1992-09-06 |
| AU1020792A (en) | 1992-07-30 |
| DE69208271D1 (de) | 1996-03-28 |
| EP0496237B1 (en) | 1996-02-14 |
| NZ241317A (en) | 1993-08-26 |
| EP0496237A2 (en) | 1992-07-29 |
| TW203610B (xx) | 1993-04-11 |
| GB9101375D0 (en) | 1991-03-06 |
| FI920247A (fi) | 1992-07-23 |
| IE920173A1 (en) | 1992-07-29 |
| HUT60492A (en) | 1992-09-28 |
| EP0496237A3 (en) | 1992-12-09 |
| FI920247A0 (fi) | 1992-01-20 |
| JPH04321683A (ja) | 1992-11-11 |
| AU641837B2 (en) | 1993-09-30 |
| MY106807A (en) | 1995-07-31 |
| IL100646A (en) | 1995-11-27 |
| MX9200178A (es) | 1992-07-01 |
| KR920014806A (ko) | 1992-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY131096A (en) | N-imidazolyl derivatives of substituted indole. | |
| NL300815I2 (xx) | ||
| NZ514873A (en) | 4,5,6,7-tetrahydroindazole derivatives as antitumor agents | |
| TWI265029B (en) | Formulations for pharmaceutical agents ionizable as free acids or free bases | |
| LU91943I2 (fr) | Tafluprost et ses dérivés pharmaceutiquement acceptables (SAFLUTAN®) | |
| ATE217623T1 (de) | Azindolethylaminderivate als nikotin-acetylcholin-rezeptor bindung verbindungen | |
| JP2005506368A5 (xx) | ||
| ZA92428B (en) | N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept(b)indole | |
| EP0546181A4 (en) | Indole derivative and medicine | |
| DE10199016I2 (de) | Indol derivate zur Behandlung von Migraene | |
| DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| PL312471A1 (en) | Benzene derivatives effective in ischaemia diseases | |
| PT728748E (pt) | Novos derivados da benzodiazepina | |
| DE69423055D1 (de) | Indol Derivate als Glutamat Antagonisten | |
| DK1140925T3 (da) | 3,4-Dihydro-2H-benzo[1,4]oxazinyl-methyl)-[3-(1H-indol-3-yl)-alkylaminer]-aminer | |
| ES2056025A1 (es) | Nuevos derivados de indol. | |
| GB2316944A (en) | New catechol derivatives |